Kaplan–Meier analysis performed on TCGA data showed also a negative correlation between mesenchymal GBM patients’ OS and SRSF1 expression (p-value = 0.0172, logrank test) (Figure S6, Supplementary Materials). The gene discussed is SRSF1; the disease is glioblastoma.